Literature DB >> 19918068

Dual inactivation of Hus1 and p53 in the mouse mammary gland results in accumulation of damaged cells and impaired tissue regeneration.

Stephanie A Yazinski1, Peter M K Westcott, Kelly Ong, Jan Pinkas, Rachel M Peters, Robert S Weiss.   

Abstract

In response to DNA damage, checkpoint proteins halt cell cycle progression and promote repair or apoptosis, thereby preventing mutation accumulation and suppressing tumor development. The DNA damage checkpoint protein Hus1 associates with Rad9 and Rad1 to form the 9-1-1 complex, which localizes to DNA lesions and promotes DNA damage signaling and repair. Because complete inactivation of mouse Hus1 results in embryonic lethality, we developed a system for regulated Hus1 inactivation in the mammary gland to examine roles for Hus1 in tissue homeostasis and tumor suppression. Hus1 inactivation in the mammary epithelium resulted in genome damage that induced apoptosis and led to depletion of Hus1-null cells from the mammary gland. Conditional Hus1 knockout females retained grossly normal mammary gland morphology, suggesting compensation by cells that failed to undergo Cre-mediated Hus1 deletion. p53-deficiency delayed the clearance of Hus1-null cells from conditional Hus1 knockout mice and caused the accumulation of damaged, dying cells in the mammary gland. Notably, compensatory responses were impaired following combined Hus1 and p53 loss, resulting in aberrant mammary gland morphology and lactation defects. Overall, these results establish a requirement for Hus1 in the survival and proliferation of mammary epithelium and identify a role for p53 in mammary gland tissue regeneration and homeostasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19918068      PMCID: PMC2795509          DOI: 10.1073/pnas.0904965106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Complicated tails: histone modifications and the DNA damage response.

Authors:  Genevieve M Vidanes; Carla Y Bonilla; David P Toczyski
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

2.  Increased common fragile site expression, cell proliferation defects, and apoptosis following conditional inactivation of mouse Hus1 in primary cultured cells.

Authors:  Min Zhu; Robert S Weiss
Journal:  Mol Biol Cell       Date:  2007-01-10       Impact factor: 4.138

3.  Ten genes for inherited breast cancer.

Authors:  Tom Walsh; Mary-Claire King
Journal:  Cancer Cell       Date:  2007-02       Impact factor: 31.743

4.  The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer.

Authors:  Chi Keung Cheng; Louis W C Chow; Wings T Y Loo; Tai Kwong Chan; Vivian Chan
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

5.  Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics.

Authors:  Zehan Chen; Zhan Xiao; Wen-Zhen Gu; John Xue; Mai H Bui; Peter Kovar; Gaoquan Li; Gary Wang; Zhi-Fu Tao; Yunsong Tong; Nan-Horng Lin; Hing L Sham; Jean Y J Wang; Thomas J Sowin; Saul H Rosenberg; Haiying Zhang
Journal:  Int J Cancer       Date:  2006-12-15       Impact factor: 7.396

6.  Mouse Hus1, a homolog of the Schizosaccharomyces pombe hus1+ cell cycle checkpoint gene.

Authors:  R S Weiss; C F Kostrub; T Enoch; P Leder
Journal:  Genomics       Date:  1999-07-01       Impact factor: 5.736

Review 7.  Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease.

Authors:  R William Vandivier; Peter M Henson; Ivor S Douglas
Journal:  Chest       Date:  2006-06       Impact factor: 9.410

8.  Compensatory proliferation in Drosophila imaginal discs requires Dronc-dependent p53 activity.

Authors:  Brent S Wells; Eri Yoshida; Laura A Johnston
Journal:  Curr Biol       Date:  2006-08-22       Impact factor: 10.834

9.  CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers.

Authors:  F Bertoni; A M Codegoni; D Furlan; M G Tibiletti; C Capella; M Broggini
Journal:  Genes Chromosomes Cancer       Date:  1999-10       Impact factor: 5.006

10.  Conditional inactivation of the mouse Hus1 cell cycle checkpoint gene.

Authors:  Peter S Levitt; Houchun Liu; Charlene Manning; Robert S Weiss
Journal:  Genomics       Date:  2005-08       Impact factor: 5.736

View more
  10 in total

1.  Targeted deletion of mouse Rad1 leads to deficient cellular DNA damage responses.

Authors:  Chunbo Zhang; Yuheng Liu; Zhishang Hu; Lili An; Yikun He; Haiying Hang
Journal:  Protein Cell       Date:  2011-06-02       Impact factor: 14.870

2.  Maintenance of imaginal disc plasticity and regenerative potential in Drosophila by p53.

Authors:  Brent S Wells; Laura A Johnston
Journal:  Dev Biol       Date:  2011-10-19       Impact factor: 3.582

3.  Genome Protection by the 9-1-1 Complex Subunit HUS1 Requires Clamp Formation, DNA Contacts, and ATR Signaling-independent Effector Functions.

Authors:  Pei Xin Lim; Darshil R Patel; Kelsey E Poisson; Manpreet Basuita; Charlton Tsai; Amy M Lyndaker; Bor-Jang Hwang; A-Lien Lu; Robert S Weiss
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

Review 4.  Stress signaling and the shaping of the mammary tissue in development and cancer.

Authors:  A Avivar-Valderas; H C Wen; J A Aguirre-Ghiso
Journal:  Oncogene       Date:  2014-01-13       Impact factor: 9.867

5.  Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR.

Authors:  David W Schoppy; Ryan L Ragland; Oren Gilad; Nishita Shastri; Ashley A Peters; Matilde Murga; Oscar Fernandez-Capetillo; J Alan Diehl; Eric J Brown
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

Review 6.  Removing all obstacles: a critical role for p53 in promoting tissue renewal.

Authors:  David W Schoppy; Yaroslava Ruzankina; Eric J Brown
Journal:  Cell Cycle       Date:  2010-04-01       Impact factor: 4.534

7.  Epimorphic regeneration in mice is p53-independent.

Authors:  L Matthew Arthur; Renee M Demarest; Lise Clark; Dmitri Gourevitch; Kamila Bedelbaeva; Rhonda Anderson; Andrew Snyder; Anthony J Capobianco; Paul Lieberman; Lionel Feigenbaum; E Heber-Katz
Journal:  Cell Cycle       Date:  2010-09-21       Impact factor: 4.534

8.  HUS1 as a Potential Therapeutic Target in Urothelial Cancer.

Authors:  Andrea Katharina Lindner; Tobias Furlan; Jacob J Orme; Gennadi Tulchiner; Nina Staudacher; David D'Andrea; Zoran Culig; Renate Pichler
Journal:  J Clin Med       Date:  2022-04-15       Impact factor: 4.964

9.  HUS1 regulates in vivo responses to genotoxic chemotherapies.

Authors:  G Balmus; P X Lim; A Oswald; K R Hume; A Cassano; J Pierre; A Hill; W Huang; A August; T Stokol; T Southard; R S Weiss
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

10.  Disease severity in a mouse model of ataxia telangiectasia is modulated by the DNA damage checkpoint gene Hus1.

Authors:  Gabriel Balmus; Min Zhu; Sucheta Mukherjee; Amy M Lyndaker; Kelly R Hume; Jaesung Lee; Mark L Riccio; Anthony P Reeves; Nathan B Sutter; Drew M Noden; Rachel M Peters; Robert S Weiss
Journal:  Hum Mol Genet       Date:  2012-05-09       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.